Dogwood Therapeutics (DWTX)
Develops non-opioid therapies for chemotherapy-related neuropathic pain.
$2.47
Pre-market−0.01 (−0.40%)
At close$2.48(−5.70%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions13 holders · as of Mar 31, 2026 | 157.85% | 3.62M shares | |
| Adds to | 157.85% |
2.29M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
Two share counts disagree (2.29M in the company's Sep 3, 2026 report, 33.63M elsewhere); stakes use the report.
These groups come from separate filings that can overlap, so they add to 157.85%; nothing is left for Other.
Institutions13F, as of Mar 31, 2026
13 holders · 3.62M shares · 6 new positions · 9 increased · 0 reduced · 3 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Armistice Capital, LLC | 3.28M | 143.03% | +3.28Mnew | May 15, 2026 |
| Vanguard Capital Management LLC | 132.2K | 5.76% | +132.2Knew | May 15, 2026 |
| Geode Capital Management, LLC | 79.4K | 3.46% | +62.7K | May 15, 2026 |
| Vanguard Fiduciary Trust Co | 62.7K | 2.74% | +62.7Knew | May 8, 2026 |
| Northern Trust Corp | 23.8K | 1.04% | +23.8Knew | May 14, 2026 |
| Goldman Sachs Group Inc | 14.6K | 0.64% | +14.6Knew | May 15, 2026 |
| Marshall Wace, LLP | 11.8K | 0.51% | +101 | May 15, 2026 |
| Tower Research Capital LLC (TRC) | 8.1K | 0.35% | +8.1K | May 15, 2026 |
Ownership statements13D/G · 5% or more, as filed
No 13D/G filer at 5% or more on record.
Insider tradesForm 4
Latest trades
No open-market trades in the last 12 months.
CongressHouse and Senate disclosures
Not reported.